Northern Trust’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.44M Buy
1,274,292
+79,882
+7% +$90.3K ﹤0.01% 3187
2025
Q1
$1.74M Sell
1,194,410
-110,822
-8% -$162K ﹤0.01% 2991
2024
Q4
$2.78M Buy
1,305,232
+56,693
+5% +$121K ﹤0.01% 2834
2024
Q3
$3.5M Buy
1,248,539
+210,434
+20% +$589K ﹤0.01% 2686
2024
Q2
$2.42M Buy
1,038,105
+67,038
+7% +$156K ﹤0.01% 2794
2024
Q1
$4.34M Sell
971,067
-43,278
-4% -$193K ﹤0.01% 2563
2023
Q4
$3.26M Buy
1,014,345
+153,818
+18% +$494K ﹤0.01% 2720
2023
Q3
$2.73M Sell
860,527
-1,979
-0.2% -$6.27K ﹤0.01% 2768
2023
Q2
$4.29M Buy
862,506
+63,333
+8% +$315K ﹤0.01% 2584
2023
Q1
$3.95M Sell
799,173
-31,231
-4% -$154K ﹤0.01% 2599
2022
Q4
$5.22M Sell
830,404
-335,206
-29% -$2.11M ﹤0.01% 2458
2022
Q3
$12.6M Buy
1,165,610
+413,301
+55% +$4.46M ﹤0.01% 1823
2022
Q2
$8.58M Buy
752,309
+53,229
+8% +$607K ﹤0.01% 2141
2022
Q1
$6.37M Sell
699,080
-25,637
-4% -$234K ﹤0.01% 2437
2021
Q4
$10.8M Buy
724,717
+11,215
+2% +$167K ﹤0.01% 2179
2021
Q3
$18.3M Sell
713,502
-21,592
-3% -$555K ﹤0.01% 1862
2021
Q2
$19.2M Buy
735,094
+86,630
+13% +$2.26M ﹤0.01% 1916
2021
Q1
$22.9M Sell
648,464
-20,143
-3% -$711K ﹤0.01% 1717
2020
Q4
$16.9M Sell
668,607
-12,980
-2% -$328K ﹤0.01% 1915
2020
Q3
$25.7M Buy
681,587
+8,969
+1% +$338K 0.01% 1433
2020
Q2
$28.8M Buy
672,618
+154,124
+30% +$6.6M 0.01% 1320
2020
Q1
$10.1M Buy
518,494
+6,479
+1% +$126K ﹤0.01% 1864
2019
Q4
$13.3M Sell
512,015
-15,965
-3% -$415K ﹤0.01% 1993
2019
Q3
$14.4M Buy
527,980
+216,959
+70% +$5.91M ﹤0.01% 1913
2019
Q2
$8.35M Buy
311,021
+20,971
+7% +$563K ﹤0.01% 2262
2019
Q1
$8.39M Buy
290,050
+3,810
+1% +$110K ﹤0.01% 2260
2018
Q4
$7.71M Buy
+286,240
New +$7.71M ﹤0.01% 2234